Skip to main content

Table 2 Association between histological subtypes of endometrial carcinoma and either/or co-expression of mesothelin and CA125

From: Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis

Histological type Mesothelin expression CA125 expression Co-expression of mesothelin and CA125
Positive Negative p-value Positive Negative p-value Positive Negative p-value
(n = 171) (n = 314) (n = 368) (n = 117) (n = 167) (n = 318)
Grade 1 endometrioid carcinoma 65 (38%) 155 (49%) 0.027 182 (49%) 38 (32%) < 0.01 64 (38%) 156 (49%) 0.048
Grade 2 endometrioid carcinoma 45 (26%) 63 (20%)   80 (22%) 28 (24%)   43 (26%) 65 (21%)  
Grade 3 endometrioid carcinoma 20 (12%) 45 (15%)   37 (10%) 28 (24%)   20 (12%) 45 (14%)  
Other carcinomas 41 (24%) 51 (16%)   69 (19%) 23 (20%)   40 (24%) 52 (16%)  
  1. Other carcinomas, carcinomas, including serous carcinoma, clear cell carcinoma, carcinosarcoma, and mixed carcinoma